Literature DB >> 8036827

Intensive regional vaccination with a gI-deleted vaccine markedly reduces pseudorabies virus infections.

J A Stegeman1, M J Tielen, T G Kimman, J T Van Oirschot, W A Hunneman, F W Berndsen.   

Abstract

The development of marker vaccines against pseudorabies virus (PRV) and companion diagnostic tests have enabled us to perform a unique field trial. In this study, the effect of intensive regional vaccination on pig-finishing herd immunity was directly measured by comparing the seroprevalence of antibodies to glycoprotein I in trial and control groups. The seroprevalence of infected finishing herds in the trial region decreased from 81% at the start of the trial to 19% after 2 years (p < 0.001). The mean seroprevalence of infected pigs in these herds diminished from 49 to 5% (p < 0.001). In the control group, representing routine PRV control, no significant change in seroprevalences was noticed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8036827     DOI: 10.1016/0264-410x(94)90312-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

Review 1.  Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae.

Authors:  L Jacobs
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

2.  Immunization of pigs to prevent disease in humans: construction and protective efficacy of a Salmonella enterica serovar Typhimurium live negative-marker vaccine.

Authors:  Martin Selke; Jochen Meens; Sven Springer; Ronald Frank; Gerald-F Gerlach
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.